Contact
Please use this form to send email to PR contact of this press release:
FDA Grants GENFIT’s GNS561 Orphan Drug Designation for the Treatment of Cholangiocarcinoma
TO:
Please use this form to send email to PR contact of this press release:
FDA Grants GENFIT’s GNS561 Orphan Drug Designation for the Treatment of Cholangiocarcinoma
TO: